BNET Industries
Market Cap:$209.6M
Last Fiscal Year Sales:$69.2M
- Public
- US
Dow Jones Description
Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus is developing products for the treatment of hemorrhagic and ischemic stroke. Both hemorrhagic and ischemic stroke are significant causes of death worldwide. Micrus product lines consist of endovascular systems that enable a physician to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus also sells accessory devices and products used in neurovascular procedures.
Chairman & CEO
John T. KilcoyneNumber of Employees 333
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
Recent Events
-
Micrus Endovascular Reports Fiscal Second Quarter Revenues
-
Micrus Endovascular Inks Licensing and Development Pact with Flexible Stenting Solutions
-
Micrus Endovascular Reports Fiscal First Quarter EPS of $0.14 and Record Quarterly Revenues of $21.2...
News & Analysis
Filter by
micrus endovascular corp. - All News and Analysis
Micrus Endovascular Corporation Q3 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions John Kilcoyne While we're waiting for the first question, I'd like to inform you that we'll be presenting at the Cowan and Company 29th Annual Heath Conference being held on March 16 through 19 in Boston. We will announce presentation dates and times in...
Micrus Endovascular Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
Earnings Call ExcerptMicrus Endovascular Corporation MEND F2Q09 (Qtr End 09/30/08) Earnings Call Transcript November 6, 2008, 10:30 am ET Executives Jody Cain – IR, Lippert Heilshorn & Associates John Kilcoyne – Chairman and CEO Gordon Sangster – CFO Bob Stern – President and COO Analysts Amit Hazan – Oppenheimer...
Micrus Endovascular Corporation F1Q09 (Qtr End 06/30/08) Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions John Kilcoyne While we are waiting for the first question, I’d like to inform you all that we will be presenting at the 2008 UBS Global Life Sciences Conference beginning September 22 through 25 in New York City. Should we attending this...
Wallstrip: Micrus Endovascular Corp. (MEND)
Micrus Endovascular Corp. is in the business of prolonging life, and overseas markets appear to be just what the doctor ordered.
Micrus Endovascular Q4 2008, Earnings Call Transcript
Question-and-Answer SessionOperator Thank you. Your first question comes from the line of Amit Hazan, Oppenheimer. John Kilcoyne Good morning, Amit. Operator Mr. Hazan your line is now open. Angela Woodall Can you hear me? John Kilcoyne Yeah. Angela Woodall Okay. My question is actually on...
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Micrus Endovascular Corp. (NASDAQ: MEND)
On October 2, 2007, a class action lawsuit was filed in the United States District Court for the Southern District of Florida against Micrus Endovascular Corp. (NASDAQ: MEND). The complaint alleges violations of federal securities laws, Sections 10b and 20a of the Securities Exchange Act of 1934 and Rule...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Robert A. Stern | President & Chief Operating Officer |
| Gordon Sangster | Chief Financial Officer |
| David A. Watson | Vice President of Research and Development |
| Edward F. Ruppel | Vice President, Technical Operations |
| Robert C Colloton | Vice President, US Sales and Global Marketing |
| William G Rigas | Vice President of Sales, Asia and Latin America |
| Francis J. Shammo | Director |
| Gregory H. Wolf | Director |
| Jeffrey H. Thiel | Director |
| L Hopkins | Director |
| Michael L. Eagle | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| John T. Kilcoyne | Chairman & CEO |
| Fred Holubow | Board of Directors |
| Michael R. Henson | Board of Directors |
Mr. Kilcoyne, Micrus' Chief Executive Officer, was elected Chairman in September 2007. Prior Mr. Kilcoyne had served as our President and CEO since December 2004. From April 2002 to April 2004, Mr. Kilcoyne served as the President and Chief Executive Officer of Solace Therapeutics, Inc., a medical device company. From November 1997 to January 2002, he served as the President and Chief Executive Officer of Endonetics, Inc., a medical device company. From February 1997 to November 1997, he served as the Vice President Sales and Marketing and New Business Development at Medical Scientific, Inc., a medical device company. From July 1993 to February 1997, he served as the Director of Marketing at Microsurge, Inc., a medical device company. Mr. Kilcoyne served in various sales and marketing positions with Guidant and Boston Scientific. Mr. Kilcoyne received his B.S. from Cornell University. Mr. Kilcoyne serves as a member of the board of directors of Onset Medical, a private company.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Chairman & CEO | Current |
| Micrus Endovascular Corporation | President | Former |
| Medical Scientific Inc | Vice President Sales and Marketing | Former |
| Guidant Corporation | Former | |
| Boston Scientific Corporation | Former | |
| Cornell University | B.S. | Former |
Mr. Stern was promoted to President and Chief Operating Officer in September 2007. Prior Mr. Stern had served as our Executive Vice President and Chief Financial Officer since November 2004, and Vice President, Finance and Administration and Chief Financial Officer since January 2004 and was appointed our Secretary in March 2005. From September 2000 to January 2004, Mr. Stern served as the President and Chief Executive Officer of Context Connect, Inc., a telecommunications company. From March 2000 to September 2000, he served as the Executive Vice President of Quixel Capital Group, an investment holding company. From January 1996 to March 2000, he served as the Vice President and Chief Financial Officer of InnerDyne, Inc., a medical device company. From October 1991 to January 1996, he served as Vice President, Corporate Finance and Chief Financial Officer of RhoMed Incorporated, a pharmaceutical company. Mr. Stern received his B.S. in Business Administration from the University of New Hampshire, Whittemore School of Business and Economics, and his MBA from the University of New Mexico, Anderson School of Management. Mr. Stern serves as a member of the board of directors of UltraTouch Corporation, a private company, and Context Connect, Inc
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | President & Chief Operating Officer | Current |
| Ultratouch Corporation | Member of the Board of Directors | Current |
| Context Connect, Inc. | President and Chief Executive Officer | Former |
| Micrus Endovascular Corporation | Executive Vice President, Chief Financial Officer | Former |
| Micrus Endovascular Corporation | Secretary | Former |
| The University of New Mexico | Mba | Former |
| University of New Hampshire | B.S. In Business Administration | Former |
Mr. Sangster, 55, joined Micrus in November 2007 as our Chief Financial Officer. He most recently served as Vice President of Finance and Chief Financial Officer of HemoSense, Inc., a publicly traded point-of-care clinical diagnostics company. From August 2000 through October 2006, Mr. Sangster was Chief Financial Officer of A.P. Pharma, Inc., a publicly traded specialty pharmaceutical company. From April 1993 to July 2000, he served as A.P. Pharma's vice president of finance and controller. He is a member of the Institute of Chartered Accountants in England and Wales
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Chief Financial Officer | Current |
| A.P. Pharma, Inc. | Cfo | Current |
| A.P. Pharma, Inc. | Vice President of Finance | Current |
| A.P. Pharma, Inc. | Board of Directors | Current |
| HemoSense, Inc. | Vice President of Finance & Chief Financial Officer | Former |
| Raychem | Manager | Former |
| A.P. Pharma, Inc. | Corporate Controller | Former |
| Coopervision, Inc. | Controller | Former |
Mr. Watson has served as our Vice President of Research and Development since October 2004. From July 1999 to September 2004, Mr. Watson acted as an engineering and program management consultant to companies in the medical device industry, including Control Delivery Systems, Inc. from August 1999 to September 2004. From June 2001 to December 2002, he served as the Director of Engineering and Product Development for Control Delivery Systems, Inc., a medical device company. From September 1995 to July 1999, he served as Director of Engineering and Program Management, Director of Engineering and Associate Director, Engineering Development at Cythotherapeutics, Inc. Mr. Watson received his B.S. in Mechanical Engineering from California Polytechnic State University.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Vice President of Research and Development | Current |
| Control Delivery Systems, Inc. | Director of Engineering | Former |
| California Polytechnic State University | B.S. In Mechanical Engineering | Former |
Mr. Ruppel joined us in June 2003 and is our Vice President, Technical Operations. From March 2001 to March 2003, Mr. Ruppel served as the Vice President of Operations of CBYON, Inc., a surgical navigation software and equipment company. From June 1994 to December 2000, he served as Director of Operations, among other management positions, for Biometric Imaging, a subsidiary of Becton, Dickinson & Company, a medical technology company. Mr. Ruppel received his B.S. in Mechanical Engineering at the University of Rochester.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Vice President, Technical Operations | Current |
| Becton, Dickinson & Company | Former | |
| University of Rochester | B.S. In Mechanical Engineering | Former |
Mr. Colloton joined us in March 2005 and is our Vice President, US Sales and Global Marketing. From February 2003 to March 2005, Mr. Colloton served as the Vice President, Account and Market Development of VNUS Medical Technologies, Inc., a medical device company. Prior to this position, he also held the positions of Vice President, Worldwide Marketing and International Sales from April 2001 to February 2003 and Vice President, Worldwide Sales and Marketing from June 1999 to April 2001, at VNUS Medical Technologies, Inc. From June 1997 to June 1999, Mr. Colloton served as Vice President, Sales and Marketing of TransVascular, Inc., a medical device company. From January 1993 to June 1997, he served in various sales and marketing executive positions at Cardiometrics, Inc. Mr. Colloton received his B.S. in Business Administration at Miami University in Oxford, Ohio.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Vice President, US Sales and Global Marketing | Current |
| VNUS Medical Technologies, Inc. | Vice President, Accounting & Market Dev | Current |
| TransVascular, Inc. | Vice President, Sales and Marketing | Former |
Mr. Rigas joined us in November 2004 and is our Vice President of Sales, Asia and Latin America. From October 2003 to November 2004, Mr. Rigas served as Vice President of Sales and Marketing of Bioplate Inc., a manufacturer of neurosurgical and cranial facial products. From March 2002 to November 2003, he served as Managing Partner of Neurox Inc., a medical device company. Mr. Rigas also served as the Director International Sales and Marketing of Microtherapeutics Inc., from March 2001 to March 2002. From November 1998 to January 2001, Mr. Rigas served as Vice President Worldwide Sales & Marketing of Radiance Medical Systems, a medical device company. Mr. Rigas also served as Vice President Worldwide Sales from June 1993 to December 1997 and as Vice President Sales and Marketing from June 1991 to July 1993 of Neuro Navigational Corporation, a manufacturer of neurosurgery products. Mr. Rigas received his B.S. from California State University, Long Beach.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Vice President of Sales, Asia and Latin America | Current |
| Bioplate, Inc. | Vice President of Sales and Marketing | Former |
| Micro Therapeutics, Inc. | Director | Former |
| California State University, Long Beach | B.S. | Former |
Mr. Shammo has served as our director since July 2004. Since 2003, Mr. Shammo has served as President of the West Area for Verizon Wireless, a telecommunications company. From 1995 to 2003, Mr. Shammo served as Vice President and Controller of Verizon Wireless. Mr. Shammo is a Certified Public Accountant. He received his B.S. in accounting from the Philadelphia College of Textiles and Science and his MBA from LaSalle University.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Director | Current |
| Verizon Wireless, Inc. | President | Former |
| Verizon Wireless, Inc. | Vice President and Controller | Former |
| La Salle University | Mba | Former |
| Philadelphia University | Bachelor's Degree In Accounting | Former |
Mr. Holubow has served as our director since July 1999. Since January 2001, Mr. Holubow has been a Managing Director of William Harris Investors, a registered investment advisory firm. From August 1982 to January 2001, Mr. Holubow served as Vice President of Pegasus Associates, a registered investment advisory firm he co-founded. He is a director of BioSante Pharmaceuticals, Inc, a pharmaceuticals company. He received his B.S. from the Massachusetts Institute of Technology and his MBA from the University of Chicago
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Board of Directors | Current |
Mr. Wolf served as the President of CIGNA Group Insurance as well as its subsidiaries, CIGNA Life Insurance Company of New York and Life Insurance Company of North America from 2002 to 2005. Mr. Wolf joined CIGNA in 2001 as a Division President to lead a new business development initiative. From 2000 to 2001, Mr. Wolf was Chairman and Chief Executive Officer of nextHR.com, an application service provider of human resource asset management services. From 1995 to 1999, Mr. Wolf held various positions with Humana, Inc., including Senior Vice President of Sales and Marketing, Chief Operating Officer, President and Chief Executive Officer. Mr. Wolf is a graduate of Penn State University and Central Michigan University.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Director | Current |
| CIGNA Corporation | Division President | Former |
| Humana Inc. | Former | |
| The Pennsylvania State University | Former | |
| Central Michigan University | Former |
Mr. Thiel has served as our director since 1999. Since 2003, Mr. Thiel has served as President, Chief Executive Officer and Director of Devax, Inc., a medical device company. From January 2001 until June 2002, Mr. Thiel served as President and Chief Executive Officer of Radiance Medical Systems, Inc., a medical device company. Prior to that, Mr. Thiel served as President and Chief Operating Officer of Radiance Medical Systems, Inc. from February 1999 until January 2001, and as Vice President of Operations from October 1996 until February 1999. Mr. Thiel received his B.S. in Economics from the University of Wisconsin-River Falls, and his MBA from the College of St. Thomas.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Director | Current |
| University of Wisconsin-River Falls | B.S. In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| The State University of New York | Director of the Toshiba Stroke Research Center | Current |
| Radiology | Professor | Current |
| State University of New York at Buffalo | Professor | Current |
| Sapient Capital Management, LLC | Special Sapient Network Member | Current |
| Northpoint Domain, Inc. | Chair, Neuroscience Domain | Current |
| marketRx Inc. | Board of Directors | Current |
| Micrus Endovascular Corporation | Director | Current |
| The State University of New York | Professor of Radiology | Former |
| The State University of New York | Chairman of Neurosurgery | Former |
| Congress of Neurological Surgeons | Chairman of the Joint Section | Former |
| CNS, Inc. | Scientific and Annual Meeting Chairman | Former |
| Albany Medical College | M.D. | Former |
| Rutgers University | B.A. | Former |
| Albany Medical College | Graduate | Former |
| Rutgers University | Undergraduation | Former |
Mr. Eagle is chairman of the board of directors of Favrille, Inc., a publicly traded company, and a member of the board of Radiant Medical, Inc. and of Siegel-Robert Corporation, both privately held companies. Mr. Eagle is a Founding Member of Barnard Life Sciences, LLC. Mr. Eagle served as Vice President of Manufacturing for Eli Lilly and Company from 1994 through 2001 and held a number of executive management positions with Eli Lilly and its subsidiaries throughout his career there. Mr. Eagle has a degree in mechanical engineering from Kettering University and an MBA from the Krannert School of Management at Purdue University. He is chairman of the board of trustees of Kettering University, on the Dean's Senior Advisory Council of the Krannert School of Management at Purdue University and on the board of directors of the Eiteljorg Museum of American Indians and Western Art.
| Organization | Position | Status |
|---|---|---|
| Kettering University | Chairman of the Board | Current |
| Favrille, Inc. | Chairman of the Board of Directors | Current |
| Forward Ventures | Chairman of the Board | Current |
| Chicago Growth Partners | Chairman of the Board | Current |
| Micrus Endovascular Corporation | Director | Current |
| Theater & Arts Foundation | Board of Directors | Current |
| Radiant Medical, Inc. | Board of Directors | Current |
| Xtent Inc. | Board of Directors | Current |
| Somaxon Pharmaceuticals, Inc. | Board of Directors | Current |
| Siegel-Robert Inc. | Board of Directors | Current |
| IVAC Corporation | Chief Executive Officer | Former |
| Eli Lilly and Company | Vice President of Manufacturing | Former |
| Guidant Corporation | Vice President | Former |
| IVAC Corporation | Vice President of Manufacturing | Former |
| Favrille, Inc. | Director | Former |
| Krannert School of Management at Purdue University | M.B.A. | Former |
| Kettering University | Bachelor of Science Degree In Engineering | Former |
Mr. Henson has served as our director since 1996, and previously served as Chairman from 1996 to September 2007. Since 2000 Mr. Henson has served as a principal manager of the MedFocus Family of Funds, a group of venture capital funds focused on emerging medical technology. In addition, since 2003 Mr. Henson has served as a general manager of the Biostar Private Equity Investment Fund, LLC, a venture capital firm. Mr. Henson joined Endologix, Inc. formerly known as Radiance Medical Systems, Inc., a medical device company, in March 1997 as president, Chief Executive Officer and Chairman of the Board of Directors, and served as a director until November 2003. In June 1997, Mr. Henson served as Chairman of the Board, Chief Executive Officer and President of Radiance Medical Systems, Inc., and served as a director until May 2002. Prior to that, Mr. Henson served as the Chief Executive Officer of Endosonics Corporation from 1988 to 1995, and as Chairman of the Board from 1993 to 1996. Mr. Henson also serves on the board of directors of several private medical companies and a charitable organization. He received his B.S. in Business Administration from Ball State University and his MBA from Ohio State University.
| Organization | Position | Status |
|---|---|---|
| Micrus Endovascular Corporation | Board of Directors | Current |
| Endologix Inc. | President, Chief Executive Officer and Chairman of the Board | Former |
| Micrus Endovascular Corporation | Chairman | Former |
| Micrus Endovascular Corporation | Director | Former |
| Endologix Inc. | Director | Former |
| The Ohio State University | Mba | Former |
| Ball State University | B.S. In Business Administration | Former |
Executive News
-
Micrus Endovascular to Present at September Investment Conferences
-
Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
-
Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
Industry Transcripts by Seeking Alpha
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
-
Sunrise Senior Living Inc Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SRZ
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes


